Abstract
While quality of life (QOL) assessment is becoming more common, interpreting the results remains problematic. This paper demonstrates an approach to developing clinically-based interpretations for QOL outcomes, using the QLQ-C30 as an example. The results from 14 published QLQ-C30 studies which group patients by performance status, weight loss, toxicity, extent or severity of disease are collated. Groups with lower clinical status generally have worse QOL. The largest differences are between performance status groups, and the smallest differences are between groups of patients with local disease and those with metastases. The physical and role scores have the largest ranges of means across patient groups, and show the largest differences between clinical groups, while the cognitive and emotional scores have the smallest ranges of means and differences. Sicker groups have larger score standard deviations than healthier groups. Relatively large and small means and differences, and corresponding effect sizes, are presented. Collectively, the results provide a sense of the relative sizes of means and of differences, and of the types of clinical groups which give rise to them, thereby providing clinically-based benchmarks by which to interpret QLQ-C30 results.
MeSH Terms
Activities of Daily Living
Adult
Aged
Australia
Humans
Middle Aged
Neoplasms/psychology
Quality of Life
Self Concept
Severity of Illness Index
Surveys and Questionnaires
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
King M T
Centre for Health Economics Research and Evaluation, Westmead Hospital, New South Wales, Australia. king@cmed.wh.su.edu.au
References (26)
26 references, click to expand
-
Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons.
BMJ. 1995 Oct 28;311(7013):1145-8
PMID: 7580713
-
Interpretation of quality of life changes.
Qual Life Res. 1993 Jun;2(3):221-6
PMID: 8401458
-
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.
J Clin Oncol. 1994 Apr;12(4):689-94
PMID: 7512127
-
Quality of life of cancer patients with different prognoses.
Qual Life Res. 1994 Apr;3(2):143-54
PMID: 8044159
-
Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.
J Clin Oncol. 1995 May;13(5):1249-54
PMID: 7738629
-
Statistical versus quantitative significance in the socioeconomic evaluation of medicines.
Pharmacoeconomics. 1994 May;5(5):389-98
PMID: 10147230
-
Determining a minimal important change in a disease-specific Quality of Life Questionnaire.
J Clin Epidemiol. 1994 Jan;47(1):81-7
PMID: 8283197
-
Quality of life measurement in patients with oesophageal cancer.
Gut. 1995 Oct;37(4):505-8
PMID: 7489936
-
Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.
Acta Oncol. 1992;31(1):19-28
PMID: 1316770
-
The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique.
Qual Life Res. 1993 Jun;2(3):193-203
PMID: 8401455
-
Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.
Acta Oncol. 1992;31(3):311-21
PMID: 1622651
-
Symptom status and quality of life following prostatectomy.
JAMA. 1988 May 27;259(20):3018-22
PMID: 2452905
-
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
PMID: 8433390
-
Quality of life during pelvic radiotherapy.
Acta Obstet Gynecol Scand. 1995 Feb;74(2):147-52
PMID: 7900512
-
Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses.
Qual Life Res. 1993 Apr;2(2):129-40
PMID: 8518767
-
Measuring quality of life: an emerging science.
Semin Oncol. 1994 Oct;21(5 Suppl 10):48-60; discussion 60-3
PMID: 7973770
-
Quality-of-life assessment in unselected oncologic out-patients - a pilot-study.
Int J Oncol. 1994 Jun;4(6):1393-7
PMID: 21567068
-
A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index--cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30).
J Clin Epidemiol. 1996 Jan;49(1):21-9
PMID: 8598507
-
Measurement of health status. Ascertaining the minimal clinically important difference.
Control Clin Trials. 1989 Dec;10(4):407-15
PMID: 2691207
-
Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy.
Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):847-56
PMID: 8138437
-
Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial.
Qual Life Res. 1994 Oct;3(5):339-52
PMID: 7531054
-
Sample sizes for studies using the short form 36 (SF-36)
J Epidemiol Community Health. 1995 Dec;49(6):642-4
PMID: 8596102
-
Lessons learned from measuring health-related quality of life in oncology.
J Clin Oncol. 1994 Mar;12(3):608-16
PMID: 8120561
-
Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
J Clin Oncol. 1995 Sep;13(9):2317-23
PMID: 7666089
-
Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
Qual Life Res. 1994 Oct;3(5):353-64
PMID: 7841968
-
Quality of life and clinical trials.
Lancet. 1995 Jul 1;346(8966):1-2
PMID: 7603136